POY_1170x120_8-12-19

Paul Urick

Saban to succeed Urick as Diplomat president

FLINT, Mich. — Diplomat Pharmacy recently announced the appointment of Joel Saban as the new company president. Paul Urick has decided to pursue other interests and will serve as president emeritus during a planned 90-day transition period. “During his tenure, Paul has served us in multiple leadership roles since he joined Diplomat with the acquisition

Joel Saban tabbed as Diplomat Pharmacy president

Joel Saban tabbed as Diplomat Pharmacy president

FLINT, Mich. — Diplomat Pharmacy Inc. has named Joel Saban as president, taking over from Paul Urick, who’s leaving the company to pursue other interests. The nation’s largest independent specialty pharmacy said late Monday that Urick will serve as president emeritus during a 90-day transition period. Saban had served as executive vice president of pharmacy

Urick becomes Diplomat president

FLINT, Mich. — Paul Urick has been promoted to president of Diplomat Pharmacy Inc. Urick, who had been senior vice president of industry relations, pharmaceutical account management and payor strategy, succeeds Gary Kadlec, who will retire on December 31. Kadlec will serve out his term on the specialty pharmacy company’s board of directors. “As part

Diplomat strengthens executive team

FLINT, Mich. — Diplomat Pharmacy has announced three promotions within the company’s executive leadership team. Atheer Kaddis has been appointed executive vice president of sales and strategic alignment, a position in which he coordinates Diplomat’s strategies within the business units. Lance Neill has been named senior vice president of corporate services and is responsible for

Diplomat promotes Urick to senior VP

Diplomat promotes Urick to senior VP

FLINT, Mich. — Paul Urick has been promoted to senior vice president of industry relations for pharmaceutical account management and payer strategies at Diplomat Pharmacy Inc. In his expanded role, Urick will now drive efforts in payer strategies through the development of specialty initiatives to reduce costs through patient-centered care, while also continuing to lead